Jamie Christensen - 24 May 2021 Form 4 Insider Report for Mirati Therapeutics, Inc.

Role
EVP, Chief Scientific Officer
Signature
/s/ Vickie Reed, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
24 May 2021
Net transactions value
-$67,138
Form type
4
Filing time
25 May 2021, 18:04:46 UTC
Next filing
07 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Sale $67,138 -435 -0.8% $154.34 53,850 24 May 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on May 21, 2020.